Oligonucleotide Therapeutics as a New Class of Drugs for Malignant Brain Tumors: Targeting mRNAs, Regulatory RNAs, Mutations, Combinations, and Beyond

DOI: 10.1007/s13311-018-00702-3

Keywords: brain tumors, microRNA, long noncoding RNA, mutations, epigenetics, gene editing.

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text